ask="4.20"
ask_size="2600"
average_daily_volume="126920"
bid="N/A"
bid_size="N/A"
book_value="2.84"
change="+0.30"
change_from_200_day_moving_average="0.36"
change_from_50_day_moving_average="1.21"
change_from_52_week_high="-2.29"
change_From_52_week_low="2.10"
change_in_percent="+7.89%"
close="4.10"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.04"
ebitda="-37.85M"
eps_estimate_current_year="-2.23"
eps_estimate_next_quarter="-0.30"
eps_estimate_next_year="-1.12"
ex_dividend_date="N/A"
float_shares="5860000"
high="4.10"
high_52_weeks="6.39"
last_trade_date="3/16/2017"
last_trade_price="4.10"
last_trade_size="200"
last_trade_time="4:00pm"
low="3.85"
low_52_weeks="2.00"
market_capitalization="86.94M"
moving_average_200_day="3.74"
moving_average_50_day="2.89"
name="Strongbridge Biopharma plc"
notes="N/A"
one_year_target_price="18.00"
open="3.90"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+9.59%"
percent_change_from_50_day_moving_average="+41.87%"
percent_change_from_52_week_high="-35.84%"
percent_change_from_52_week_low="+105.00%"
previous_close="3.80"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.34"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21205000"
short_ratio="0.90"
stock_exchange="NMS"
symbol="SBBP"
volume="61855"
weeks_range_52="2.00 - 6.39"
